SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed veteran medtech finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026. The appointment adds significant public-company financial and capital markets experience as the company accelerates its global expansion and advances regulatory initiatives for its SSi Mantra robotic surgical platform.
Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology. She has raised over $100 million during her career and previously served as CFO at Vicarious Surgical, another robotic surgical technology developer, where she oversaw financial and operational initiatives to reduce cash burn and strengthen the balance sheet.
The leadership addition comes as SS Innovations continues pursuing U.S. Food and Drug Administration clearance for its SSi Mantra system. The company is also expanding internationally, with recent training programs underscoring its commitment to surgeon education alongside technology deployment. The SS International Centre for Robotics Surgery (SSICRS) recently graduated its inaugural class of a cardiac robotic surgery training program, welcoming 33 healthcare professionals from seven countries.
SS Innovations' focus on both regulatory approval and global education reflects a strategic approach to market penetration. The company aims to differentiate itself by ensuring surgeons are well-trained on its platform, which could facilitate adoption in new markets. The appointment of Romano, with her experience in capital markets and financial restructuring, signals a focus on financial discipline as the company scales operations.
For more information on SS Innovations' regulatory progress, see the company's FDA update at https://nnw.fm/yY4UM. Additional news and updates are available in the company's newsroom at https://ibn.fm/SSII.
Forward-looking statements in this release involve risks and uncertainties, as detailed in the company's SEC filings. SS Innovations undertakes no duty to update these statements unless required by law.
